Combination Product Rules Clear OMB, To Be Released In Weeks

Two key proposed rules from FDA's Office of Combination Products have finally received Office of Management and Budget approval and should be out for comment in the coming weeks, according to OCP Director Thinh Nguyen

More from Archive

More from Medtech Insight